Lisata Therapeutics, Inc.LSTANASDAQ

Revenue (LTM)

$170000

-83.0% YoY

Net Income (LTM)

$-17M

+17.0% YoY

Free Cash Flow

$-16M

Revenue CAGR (5Y)

—

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	1	0↓83.0%
Gross Profit	0	0	0	1	0↓97.6%
Operating Income	-29	-58↓98.3%	-26↑55.4%	-22↑12.8%	-18↑18.7%
Net Income	-27	-54↓97.4%	-21↑61.6%	-20↑4.1%	-17↑17.0%
EBITDA	-29	-58↓98.4%	-26↑55.6%	-22↑12.9%	-18↑18.8%
EPS Diluted	-7.45	-10.47↓40.5%	-2.58↑75.4%	-2.40↑7.0%	-1.91↑20.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	25	32↑30.5%	23↓29.7%	16↓28.3%	16↓1.6%
Total Current Assets	96	72↓25.3%	54↓25.0%	35↓35.9%	18↓48.8%
Total Assets	97	73↓24.7%	55↓25.1%	35↓36.0%	18↓49.3%
Total Current Liabilities	5	6↑41.1%	7↑3.2%	6↓14.8%	3↓45.3%
Total Liabilities	5	7↑34.0%	7↑1.3%	6↓16.4%	3↓44.7%
Total Equity	92	67↓27.8%	48↓27.7%	30↓38.6%	15↓49.8%
Total Debt	1	0↓32.1%	0↓65.4%	0↓18.5%	0
Net Debt	-24	-32↓32.3%	-22↑29.2%	-16↑28.3%	-16↑0.7%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-22	-21↑4.8%	-20↑5.4%	-19↑3.4%	-16↑17.6%
Capital Expenditure	-0	-0↓375.0%	0	0	-0
Free Cash Flow	-22	-21↑3.8%	-20↑6.6%	-19↑3.4%	-16↑17.5%
Stock-Based Comp	2	3↑31.5%	2↓22.7%	2↓18.9%	1↓25.8%
Net Change in Cash	8	8↓7.7%	-10↓227.4%	-6↑33.2%	-0↑96.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance